Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02155465
Title Trial of Ruxolitinib and Erlotinib in Patients With EGFR-mutant Lung Adenocarcinoma With Acquired Resistance to Erlotinib
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Memorial Sloan-Kettering Cancer Center
Indications

lung cancer

Therapies

Erlotinib + Ruxolitinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Memoral Sloan Kettering Cancer Center Basking Ridge New Jersey United States Details
Memorial Sloan Kettering Cancer Center @ Suffolk Commack New York 11725 United States Details
Memorial Sloan Kettering West Harrison Harrison New York 10604 United States Details
Memorial Sloan Kettering Cancer Center New York New York 10065 United States Details
Memorial Sloan Kettering at Mercy Medical Center Rockville Centre New York United States Details
Memoral Sloan Kettering Cancer Center at Phelps Sleepy Hollow New York 10591 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field